Latest News

• Crude oil prices rises but rising production from the U.S. has spooked traders

  Publish Date :2017-06-23

  The crude oil moves higher on Thursday but traders were worried about the strong shale production output growth in the United Statesadverse to Wednesday’s drop in oil prices by more than 2% to the lowest in 10 months.

• Cigna to invest billions in Medicare advantage and several other sectors this year

  Publish Date :2017-06-23

  The Chief Executive of Cigna Corp, Mr. David Cordani announced during investorsmeeting that Cigna Corp has around USD 7 billion to USD 14 billion in capital.It could be used this year for mergers and acquisitions in several areas, as well ...

• A newly developed blood test may be used to inspect prostate cancer treatment

  Publish Date :2017-06-20

  A new prostate cancer blood test can facilitate to target treatment by analyzing cancerous cells more precisely.

• New antibiotic for serious skin infection gets FDA approval

  Publish Date :2017-06-20

  The US Food and Drug Administration (FDA) on Friday, approved new antibiotic called delafloxacin to treat serious and acute bacterial skin infections, including one which is mostly tough to beat.

• Pharmaceutical giants Verily and Novartis to support new USD300 million Medicxi fund

  Publish Date :2017-06-20

  Novartis and verily are two of the world’s largest pharmaceutical companies back new Medicxi fund worth USD300 million.

• Pfizer has inked deal with Basilea over Cresemba selling rights.

  Publish Date :2017-06-20

  Pfizer has signed a deal with the Basilea Pharmaceutica regarding rights to sell Basilea's anti-fungal treatment, referred as Cresemba (isavuconazole) in Russia, Turkey and Israel and Europe.

• New temperature-resistant vaccine being developed for rabies and yellow fever at KU Leuven

  Publish Date :2017-06-20

  Rabies and yellow fever causes ten thousand deaths each year. Although vaccines are available for these diseases but there are various drawbacks. Some of them are available at higher cost, and there is an inadequate supply.

• Integral Molecular initiates a therapeutic target discovery program in immuno-oncology

  Publish Date :2017-06-20

  The Membrane Proteome Array, which is a cell-based testing platform, compiled of 5,300 distinctive membrane proteins carried in live human cells.

• Higher bleeding risk in elderly with daily aspirin

  Publish Date :2017-06-20

  New research suggests that, prolonged daily use of aspirin may cause considerably high risk of serious or even fatal bleeding in people who are aged 75 or older.

• High risk involved in treatment of Type 2 Diabetes

  Publish Date :2017-06-20

  American Diabetes Association’s (ADA’s) 77th Scientific Sessions held in San Diego, California, US. During that session, a seminar was given regarding the overtreatment of type 2 diabetes (T2D).